Panuveitis in patient on ipilimumab/nivolumab combination for small-cell lung cancer treated with an intravitreal dexamethasone implant.

Jade L HeflerLauren M BaileyCynthia El-RahiAmy C ScheflerEric H Bernicker

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2020)

This case highlights the importance of early recognition of ocular irAEs by ocular oncologists and the successful approach to treatment of immunotherapy-induced panuveitis in order to avoid permanent cessation of therapy.

Keyphrases

small cell lung cancer
high glucose
case report
diabetic rats
low dose
vascular endothelial growth factor
high dose
optic nerve
brain metastases
soft tissue
oxidative stress
combination therapy
mesenchymal stem cells
bone marrow
advanced cancer
age related macular degeneration
replacement therapy
palliative care